LCN2 and acute myeloid leukemia: A few studies measuring NGAL protein levels in the bone marrow (BM) of patients with hematological cancer reported that NGAL levels were significantly lower in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) than in controls 8-10.